307 related articles for article (PubMed ID: 7547982)
1. Recognition of DNA interstrand cross-links of cis-diamminedichloroplatinum(II) and its trans isomer by DNA-binding proteins.
Kaspárková J; Brabec V
Biochemistry; 1995 Sep; 34(38):12379-87. PubMed ID: 7547982
[TBL] [Abstract][Full Text] [Related]
2. Characterization of a DNA damage-recognition protein from mammalian cells that binds specifically to intrastrand d(GpG) and d(ApG) DNA adducts of the anticancer drug cisplatin.
Donahue BA; Augot M; Bellon SF; Treiber DK; Toney JH; Lippard SJ; Essigmann JM
Biochemistry; 1990 Jun; 29(24):5872-80. PubMed ID: 2383564
[TBL] [Abstract][Full Text] [Related]
3. Replacement of an NH(3) by an iminoether in transplatin makes an antitumor drug from an inactive compound.
Leng M; Locker D; Giraud-Panis MJ; Schwartz A; Intini FP; Natile G; Pisano C; Boccarelli A; Giordano D; Coluccia M
Mol Pharmacol; 2000 Dec; 58(6):1525-35. PubMed ID: 11093793
[TBL] [Abstract][Full Text] [Related]
4. DNA binding mode of the cis and trans geometries of new antitumor nonclassical platinum complexes containing piperidine, piperazine, or 4-picoline ligand in cell-free media. Relations to their activity in cancer cell lines.
Kasparkova J; Marini V; Najajreh Y; Gibson D; Brabec V
Biochemistry; 2003 May; 42(20):6321-32. PubMed ID: 12755637
[TBL] [Abstract][Full Text] [Related]
5. Superhelical torsion controls DNA interstrand cross-linking by antitumor cis- diamminedichloroplatinum(II).
Vrána O; Boudný V; Brabec V
Nucleic Acids Res; 1996 Oct; 24(20):3918-25. PubMed ID: 8918792
[TBL] [Abstract][Full Text] [Related]
6. Effect of geometric isomerism in dinuclear platinum antitumor complexes on DNA interstrand cross-linking.
Kaspárková J; Nováková O; Vrána O; Farrell N; Brabec V
Biochemistry; 1999 Aug; 38(34):10997-1005. PubMed ID: 10460154
[TBL] [Abstract][Full Text] [Related]
7. Basis for recognition of cisplatin-modified DNA by high-mobility-group proteins.
Ohndorf UM; Rould MA; He Q; Pabo CO; Lippard SJ
Nature; 1999 Jun; 399(6737):708-12. PubMed ID: 10385126
[TBL] [Abstract][Full Text] [Related]
8. Thermodynamic properties of duplex DNA containing a site-specific d(GpG) intrastrand crosslink formed by an antitumor dinuclear platinum complex.
Hofr C; Farrell N; Brabec V
Nucleic Acids Res; 2001 May; 29(10):2034-40. PubMed ID: 11353072
[TBL] [Abstract][Full Text] [Related]
9. DNA binding by antitumor trans-[PtCl2(NH3)(thiazole)]. Protein recognition and nucleotide excision repair of monofunctional adducts.
Kasparkova J; Novakova O; Farrell N; Brabec V
Biochemistry; 2003 Jan; 42(3):792-800. PubMed ID: 12534292
[TBL] [Abstract][Full Text] [Related]
10. HMG-domain protein recognition of cisplatin 1,2-intrastrand d(GpG) cross-links in purine-rich sequence contexts.
Cohen SM; Mikata Y; He Q; Lippard SJ
Biochemistry; 2000 Sep; 39(38):11771-6. PubMed ID: 10995245
[TBL] [Abstract][Full Text] [Related]
11. Rearrangement of interstrand cross-links into intrastrand cross-links in cis-diamminedichloroplatinum(II)-modified DNA.
Pérez C; Leng M; Malinge JM
Nucleic Acids Res; 1997 Feb; 25(4):896-903. PubMed ID: 9016644
[TBL] [Abstract][Full Text] [Related]
12. DNA modifications by a novel bifunctional trinuclear platinum phase I anticancer agent.
Brabec V; Kaspárková J; Vrána O; Nováková O; Cox JW; Qu Y; Farrell N
Biochemistry; 1999 May; 38(21):6781-90. PubMed ID: 10346899
[TBL] [Abstract][Full Text] [Related]
13. Steric control of DNA interstrand cross-link sites of trans platinum complexes: specificity can be dictated by planar nonleaving groups.
Brabec V; Neplechova K; Kasparkova J; Farrell N
J Biol Inorg Chem; 2000 Jun; 5(3):364-8. PubMed ID: 10907747
[TBL] [Abstract][Full Text] [Related]
14. Sequence specificity, conformation, and recognition by HMG1 protein of major DNA interstrand cross-links of antitumor dinuclear platinum complexes.
Kasparkova J; Farrell N; Brabec V
J Biol Chem; 2000 May; 275(21):15789-98. PubMed ID: 10747955
[TBL] [Abstract][Full Text] [Related]
15. Binding of tsHMG, a mouse testis-specific HMG-domain protein, to cisplatin-DNA adducts.
Ohndorf UM; Whitehead JP; Raju NL; Lippard SJ
Biochemistry; 1997 Dec; 36(48):14807-15. PubMed ID: 9398202
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of the formation of DNA-protein cross-links by antitumor cisplatin.
Chválová K; Brabec V; Kaspárková J
Nucleic Acids Res; 2007; 35(6):1812-21. PubMed ID: 17329374
[TBL] [Abstract][Full Text] [Related]
17. DNA sequence context modulates the impact of a cisplatin 1,2-d(GpG) intrastrand cross-link on the conformational and thermodynamic properties of duplex DNA.
Pilch DS; Dunham SU; Jamieson ER; Lippard SJ; Breslauer KJ
J Mol Biol; 2000 Feb; 296(3):803-12. PubMed ID: 10677282
[TBL] [Abstract][Full Text] [Related]
18. Transplatin-modified oligonucleotides as modulators of gene expression.
Giraud-Panis M; Leng M
Pharmacol Ther; 2000 Mar; 85(3):175-81. PubMed ID: 10739872
[TBL] [Abstract][Full Text] [Related]
19. DNA interactions of antitumor trans-[PtCl2(NH3)(quinoline)].
Zákovská A; Nováková O; Balcarová Z; Bierbach U; Farrell N; Brabec V
Eur J Biochem; 1998 Jun; 254(3):547-57. PubMed ID: 9688265
[TBL] [Abstract][Full Text] [Related]
20. Activation of trans geometry in bifunctional mononuclear platinum complexes by a piperidine ligand. Mechanistic studies on antitumor action.
Kasparkova J; Novakova O; Marini V; Najajreh Y; Gibson D; Perez JM; Brabec V
J Biol Chem; 2003 Nov; 278(48):47516-25. PubMed ID: 12970368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
